| Patents for C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294) |
|---|
| 09/25/1997 | WO1997020000A3 Improved colorant stabilizers |
| 09/24/1997 | EP0796101A1 Compositions and methods for inhibiting fungal cell wall formation |
| 09/18/1997 | WO1997033593A1 A product of heat treatment of uronic acid, food, drink or drug including the product |
| 09/18/1997 | CA2248648A1 A product of heat treatment of uronic acid, food, drink or drug including the product |
| 09/12/1997 | WO1997021416A3 Glycoconjugates of opiated substances |
| 08/20/1997 | CN1035673C Preparation method for megnesium gluconate for medicine use |
| 08/14/1997 | WO1997028807A1 Anticancer substance suppressing cancerous metastasis |
| 07/31/1997 | WO1997027205A1 Imidazo[1,2-a]pyridine c-nucleosides as antiviral agents |
| 07/31/1997 | WO1997027204A1 Modified benzimidazole nucleosides as antiviral agents |
| 07/31/1997 | CA2244378A1 Modified benzimidazole nucleosides as antiviral agents |
| 07/30/1997 | EP0786458A2 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents |
| 07/15/1997 | US5648379 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents |
| 07/15/1997 | US5648344 Methods of treating inflammation using selection binding compounds |
| 07/03/1997 | WO1997023637A1 Galactopyranosides and their use |
| 07/03/1997 | CA2240941A1 Galactopyranosides and their use |
| 06/22/1997 | CA2193034A1 Enhanced process for the oxidation of sugars |
| 06/19/1997 | WO1997021416A2 Glycoconjugates of opiated substances |
| 06/19/1997 | CA2211596A1 Glycoconjugates of opiated substances |
| 06/12/1997 | WO1997020860A1 Process for the alcaline oxidative degradation of reducer sugars and products thus obtained |
| 06/05/1997 | WO1997020000A2 Improved colorant stabilizers |
| 06/05/1997 | CA2210480A1 Improved colorant stabilizers |
| 06/03/1997 | US5635611 Complexing detranylglucuronic acid salt with ferric hydroxide sol to form a complex; resistant to enzymatic degradation and improved water solubility |
| 06/03/1997 | US5635610 From oxidation by a microorganism belonging to the genus pseudogluconobacter; resistant to enzymatic degradation; improved water solubility |
| 05/28/1997 | EP0775709A1 Method for preparing di- and higher oxidised carboxylic acids of carbohydrates, carbohydrate derivatives or primary alcohols |
| 05/21/1997 | CN1150020A Anti-viral compounds |
| 05/15/1997 | CA2190308A1 Method and apparatus for producing di- and more highly oxidized carboxylic acids |
| 05/14/1997 | EP0772617A1 7-o-carbamoyl heptose derivatives, process for their production and their use and screening process for their detection |
| 05/13/1997 | US5629412 Polypeptide and carbohydrate |
| 05/13/1997 | US5629411 Resistant to enzymatic degration, improved water solubility |
| 04/17/1997 | WO1997003701A3 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 04/15/1997 | US5620902 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 04/10/1997 | DE19536733A1 Urea and uronic acid adducts prepn. useful in cosmetics |
| 03/25/1997 | US5614615 Sialyl Lewis X mimetics incorporating fucopeptides |
| 03/18/1997 | US5612476 Anti-endotoxin compounds |
| 03/12/1997 | EP0761661A1 Glycomimetics as selectin antagonists, and anti-inflammatory agents prepared thereof |
| 03/07/1997 | CA2184881A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity prepared therefrom |
| 03/01/1997 | CA2184564A1 Chromatographic method and its use for separation of azadirachtin |
| 02/20/1997 | WO1997005883A1 Pharmaceutical composition |
| 02/06/1997 | WO1997003701A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/06/1997 | CA2227013A1 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/04/1997 | US5599915 Inhibit selectin-mediated cellular adhesion |
| 01/28/1997 | US5597735 Spot test kit, simple, fast, reliable |
| 01/16/1997 | WO1997001569A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 01/16/1997 | WO1997001352A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 01/16/1997 | CA2225691A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 01/16/1997 | CA2224346A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 01/14/1997 | US5593887 Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| 01/07/1997 | US5591697 Plant growth regulators |
| 12/27/1996 | EP0749314A1 Method for treating and inhibiting gastric and duodenal ulcers |
| 12/19/1996 | WO1996040969A1 Method for synthesizing 2-ketoaldonic acids |
| 12/19/1996 | WO1996040169A1 Bacterial inhibition with an oligosaccharide compound |
| 12/19/1996 | CA2224102A1 Bacterial inhibition with an oligosaccharide compound |
| 12/17/1996 | US5585261 KDO aldolase |
| 12/11/1996 | EP0746564A1 4-n-substituted sialic acids and their sialosides |
| 11/19/1996 | US5576426 Aldolase catalyzed stereoselective synthesis of arabinohexulose, xyloheptulose, threohexulose and xylohexulose |
| 11/13/1996 | CN1135756A Ganglioside GM3 analog Having sialic acid residue fluorinated at the 9-position and intermediate thereof |
| 10/23/1996 | EP0738155A1 Modular design and synthesis of oxazolone-derived molecules |
| 09/26/1996 | WO1996029339A1 Fucopeptides |
| 09/26/1996 | CA2214107A1 Fucopeptides |
| 09/18/1996 | EP0731704A1 Synthetic glycoamines that promote or inhibit cell adhesion |
| 09/17/1996 | US5556836 Use of D-glucopyranuronic acids and their derivatives for incorporation in pharmacologically active peptides and their salts |
| 08/28/1996 | EP0728763A1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor |
| 07/31/1996 | EP0723550A1 Enzymatically stable alkyl (alkyl glycosid)uronates as nonionic surfactants and a process for their manufacture |
| 07/11/1996 | WO1996020717A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/11/1996 | CA2209663A1 Compositions and methods for inhibiting fungal cell wall formation |
| 06/18/1996 | US5527901 Tetrasaccharides bonding to a label, a chromatograpic support or protective group for isolating, purifying antibodies |
| 06/15/1996 | CA2138073A1 Sialic acid powder and process for the preparation thereof |
| 06/04/1996 | US5523320 For treatment of leukemia |
| 05/28/1996 | US5521160 Compounds for treatment of atheriosclerosis in blood vessels and prevention of restenosis after angioplasty |
| 05/01/1996 | EP0651734B1 Method and device for producing monocarboxylic acids from carbohydrates, carbohydrate derivates or primary alcohols |
| 04/30/1996 | US5512673 For legumes; promote growth, inhibit roots in culture |
| 03/26/1996 | US5501812 Toilet bar compositions containing glycolipid surfactants and a process for manufacturing such surfactants |
| 03/20/1996 | CN1118785A Magnesium gluconate for medicine use and its preparation method for oral liquor |
| 03/13/1996 | EP0476113B1 Medicament for treating hyperlipidaemia and/or atherosclerosis |
| 03/06/1996 | CN1031192C 3'-deamino-4'-deoxy-4'-amino-8-fluoroan-thracyclines and processes for their preparation |
| 02/22/1996 | WO1996005211A1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor |
| 02/07/1996 | CN1116207A Manufacture of 2-keto-l-gulonates |
| 02/01/1996 | WO1996002550A1 7-o-carbamoyl heptose derivatives, process for their production and their use and screening process for their detection |
| 01/30/1996 | US5488171 Intermediates for nucleotide analogs with viricide properties |
| 01/25/1996 | WO1996001639A1 Synthetic glycoamines that promote or inhibit cell adhesion |
| 01/18/1996 | DE4425098A1 7-0-Carbamoyl-Heptose-Derivate, Verfahren zu deren Herstellung und deren Verwendung sowie Screening-Verfahren zu deren Bestimmung 7-0-carbamoyl-heptose derivatives, processes for their preparation and their use, and screening procedures for their determination |
| 12/27/1995 | EP0688783A1 Method for preparing 2',deoxy-2',2'-difluornucleosides |
| 12/27/1995 | EP0688782A1 Stereoselective process for preparing protected 2',2'-difluorolactonen |
| 12/06/1995 | CN1030454C Method for prepn. of sodium salt of propyl mannuronate sulfuric ester |
| 12/06/1995 | CN1030453C Process for producing sodium salt of propyl guluronate sulfuric ester |
| 10/11/1995 | CN1109889A New sulfuric acid esters of sugar alcohols |
| 10/04/1995 | EP0674706A1 Kdo aldolase and condensation reactions employed therewith |
| 10/03/1995 | US5455345 Plant growth regulators; producing legume sprouts, inhibiting root growth |
| 09/27/1995 | EP0673947A1 Psicofuranose and psicopyranose derivatives |
| 09/19/1995 | US5451668 Process for splitting off Δ4 -unsaturated uronic acid from glycosaminoglycans |
| 09/13/1995 | EP0671405A1 Manufacture of esters of 2-keto-L-gulonic acid |
| 09/08/1995 | WO1995023605A1 Method for treating and inhibiting gastric and duodenal ulcers |
| 09/08/1995 | CA2183329A1 Method for treating and inhibiting gastric and duodenal ulcers |
| 09/05/1995 | CA1336890C Amphotericin b/cholesterol sulfate composition and method |
| 08/31/1995 | WO1995023157A1 4-n-substituted sialic acids and their sialosides |
| 08/31/1995 | CA2181237A1 4-n-substituted sialic acids and their sialosides |
| 07/19/1995 | EP0663391A1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls |
| 07/18/1995 | US5434141 Medicament for the treatment of hyperlipidaemia and/or atherosclerosis |
| 07/18/1995 | US5434061 Production of saccharide carboxylic acids |
| 07/15/1995 | CA2139720A1 Sulfuric acid esters of sugar alcohols |